Showing results (341-350 of 378) with videos related to
Sort By:
Pageof 38
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma NetworkE Terpos, O Sezer, P I Croucher, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agentsM A Dimopoulos, S Delimpasi, E Katodritou, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2010
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)P A Kosmidis, G Fountzilas, A G Eleftheraki, et al.British Journal of Cancer|June 29, 2013
Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaborationA Bamias, K Tzannis, B Beuselinck, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, C Papadimitriou, U Dafni, et al.Seminars in Hematology|April 26, 2023
Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and managementE Terpos, A R Branagan, R García-Sanz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology GroupM A Dimopoulos, C Bakoyannis, V Georgoulias, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2003
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology GroupA Bamias, G Aravantinos, C Deliveliotis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study GroupJ R Berenson, A Lichtenstein, L Porter, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myelomaM A Dimopoulos, A Pouli, K Zervas, et al.Pageof 38